New vaccine trial aims to shield korean babies from deadly meningitis
NCT ID NCT06113198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the MenB+OMV NZ vaccine in 50 healthy infants starting at 2 months old in South Korea. The vaccine is given as three shots over about a year to see if it triggers a strong immune response against meningococcal group B bacteria, which can cause meningitis. Researchers will also monitor for any side effects. The goal is to confirm the vaccine works well and is safe for this age group in Korea.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MenB+OMV NZ vaccine
- What this could lead to
- If successful, this could confirm that the vaccine protects Korean infants against meningococcal group B disease, a serious cause of meningitis.
- What could go wrong
- This is a small, single-arm study with only 50 participants, so results may not apply broadly. Side effects like fever or injection-site reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGITIS, MENINGOCOCCAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
GSK Investigational Site
Incheon, 6510, South Korea
-
GSK Investigational Site
Junggu, 400711, South Korea
-
GSK Investigational Site
Kyungki-do, 14068, South Korea
-
GSK Investigational Site
Seongnam-si Gyeonggi-do, 13620, South Korea
-
GSK Investigational Site
Seoul, 02841, South Korea
-
GSK Investigational Site
Seoul, 05505, South Korea
-
GSK Investigational Site
Seoul, 07804, South Korea
-
GSK Investigational Site
Seoul, 137701, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.